Non-corneal approach to measuring IOP revealed

Article

BiCOM showcased its Diaton tonometer at this year's AAO/MEACO meeting. The pen-like, handheld, portable device can measure eye pressure through the patient's eyelid and over the sclera.

BiCOM showcased its Diaton tonometer at this year's AAO/MEACO meeting. The pen-like, handheld, portable device can measure eye pressure through the patient's eyelid and over the sclera to enable diagnosis and prevention of blindness caused by glaucoma.

With no corneal contact, no anaesthesia or sterilization required the Diaton Tonometry approach is unique. Instead of using the Imbert-Fick law, as with Goldmann tonometry, this new approach implements Newton's Second Law and a Ballistic Principle to obtain the IOP. Readings are taken over the upper eyelid, at the tarsus and over the sclera not the cornea. This means that IOP measurements shouldn't be affected by CCT and other corneal parameters and diseases.

The company reports that a recent clinical study concluded: "Transpalpebral Tonometry is an accurate method of IOP measurement that is also independent from the biomechanical characteristics of cornea. It can be recommended for IOP measurements of patients diagnosed with glaucoma including those cases where cornea pathology or cornea characteristics have been altered."

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.